We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Kromek Group Plc | LSE:KMK | London | Ordinary Share | GB00BD7V5D43 | ORD 1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.25 | -3.33% | 7.25 | 7.00 | 7.50 | 7.55 | 7.25 | 7.55 | 651,480 | 13:44:24 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Miscellaneous Metal Ores,nec | 17.31M | -6.1M | -0.0102 | -7.16 | 43.82M |
From Apr 2019 to Apr 2024
TIDMKMK
RNS Number : 1729A
Kromek Group PLC
07 September 2018
7 September 2018
Kromek Group plc
("Kromek" or the "Company")
Notice of AGM and Posting of Annual Report
Kromek (AIM: KMK), a radiation detection technology company focusing on the medical, security and nuclear markets, announces that its Annual General Meeting ("AGM") will be held at 10.00am on 1 October 2018 at the NETPark Incubator Building, North East Technology Park (NETPark), Thomas Wright Way, Sedgefield, County Durham TS21 3FD.
The notice of AGM and form of proxy, along with the Company's annual report and accounts for the year ended 30 April 2018, have been posted to shareholders and copies are available from the Company's website: www.kromek.com.
For further information, please contact:
Kromek Group plc Arnab Basu, CEO Derek Bulmer, CFO +44 (0)1740 626 060 Cenkos Securities plc (Nominated Adviser and Joint Broker) Max Hartley (NOMAD) Julian Morse (Sales) +44 (0)20 7397 8900 Cantor Fitzgerald Europe (Joint Broker) Philip Davies Will Goode +44 (0)20 7894 7000 Luther Pendragon Ltd (PR) Harry Chathli Claire Norbury Alexis Gore +44 (0)20 7618 9100
About Kromek Group plc
Kromek Group plc is a UK technology Group (global HQ in County Durham) and a leading developer of high performance radiation detection products based on cadmium zinc telluride ("CZT") and other advanced technologies. Using its core technology platforms, Kromek designs, develops and produces x-ray and gamma ray imaging and radiation detection products for the medical, security screening and nuclear markets.
The Group's products provide high resolution information on material composition and structure and are used in multiple applications, ranging from the identification of cancerous tissues to hazardous materials, such as explosives, and the analysis of radioactive materials.
The Group's business model provides a vertically integrated technology offering to customers, from radiation detector materials to finished products or detectors, including software, electronics and application specific integrated circuits ("ASICs").
The Group has operations in the UK and US (California and Pennsylvania), and is selling internationally through a combination of distributors and direct OEM sales.
Currently, the Group has over one hundred full time employees across its global operations. Further information on Kromek Group is available at www.kromek.com and https://twitter.com/kromekgroup.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
MSCUGUAABUPRGWM
(END) Dow Jones Newswires
September 07, 2018 09:57 ET (13:57 GMT)
1 Year Kromek Chart |
1 Month Kromek Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
